Hap Trading, LLC Immunity Bio, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $57,419 - $89,364	-13,200 Reduced 29.33%	31,800 $6,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $27,375 - $48,225	7,500 Added 20.0%	45,000 $16,000
Q2 2022 Aug 12, 2022	SELL	$2.68 - $6.14 $15,008 - $34,384	-5,600 Reduced 12.99%	37,500 $11,000
Q1 2022 May 12, 2022	SELL	$5.05 - $7.53 $105,040 - $156,624	-20,800 Reduced 32.55%	43,100 $29,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $193,914 - $348,156	34,200 Added 115.15%	63,900 $80,000
Q3 2021 Nov 10, 2021	BUY	$9.17 - $14.24 $163,226 - $253,472	17,800 Added 149.58%	29,700 $19,000
Q2 2021 Aug 11, 2021	SELL	$13.41 - $22.4 $136,782 - $228,480	-10,200 Reduced 46.15%	11,900 $26,000
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $283,543 - $933,725	22,100 New	22,100 $112,000

212

70.1M

1.64M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.35B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.